Literature DB >> 18985935

Cardiovascular risk and prevalence of metabolic syndrome by differing criteria.

Wei-ju Li1, Hao Xue, Kai Sun, Xiao-dong Song, Yi-bo Wang, Yi-song Zhen, Yun-feng Han, Ru-tai Hui.   

Abstract

BACKGROUND: The prevalence of metabolic syndrome (MetS) in hypertensive population in Chinese countryside is unknown. Firstly, this study compared the prevalence of MetS according to National Cholesterol Education Program (NCEP) ATPIII, revised NCEP and International Diabetes Federation (IDF) definitions. Secondly, it investigated the association between MetS, coronary heart disease (CHD) and stroke in patients with hypertension.
METHODS: In this cross sectional study, the cluster sampling method was used. Three MetS definitions were applied to 1418 normal subjects and 5348 hypertensive patients aged 40-75 years in rural areas in China. The agreement between different MetS definitions was estimated by kappa statistics. Logistic regression analyses determined the association between MetS defined by the three MetS definitions and CHD and stroke.
RESULTS: In subjects without hypertension, the prevalence of Mets was 4.1% by NCEP definition, 8.3% revised NCEP definition and 7.8% IDF definition. In hypertensive individuals, the prevalence was 14.0%, 32.9%, and 27.4% in men; 35.6%, 53.1%, and 50.2% in women by the same definitions, respectively. In hypertensive individuals, the agreement was 94.4% in men and 97.0% in women between revised NCEP and IDF definitions. The IDF defined MetS was more strongly associated with CHD than the NCEP or revised NCEP defined MetS (adjusted odds ratio: 1.92 compared with 1.85 and 1.69 in men; 1.64 compared with 1.48 and 1.60 in women).
CONCLUSIONS: In the patients with hypertension, the revised NCEP and IDF definitions identified more individuals than NCEP definition and their agreement is very high. The IDF defined MetS is more strongly associated with CHD than the NCEP or revised NCEP defined MetS, but weakly or not associated with stroke.

Entities:  

Mesh:

Year:  2008        PMID: 18985935

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  6 in total

1.  Comparison of four definitions of the metabolic syndrome and odds of ischemic heart disease in the Lithuanian urban population.

Authors:  Dalia Ieva Luksiene; Migle Baceviciene; Abdonas Tamosiunas; Regina Reklaitiene; Ricardas Radisauskas
Journal:  Int J Public Health       Date:  2011-03-08       Impact factor: 3.380

2.  Biochemical and genetic studies on cardiometabolic syndrome.

Authors:  A Supriya Simon; D Dinesh Roy; V Jayapal; T Vijayakumar
Journal:  Indian J Clin Biochem       Date:  2010-05-27

3.  Prevalence and characteristics of the metabolic syndrome among newly diagnosed hypertensive patients.

Authors:  Charles U Osuji; Emeka G Omejua
Journal:  Indian J Endocrinol Metab       Date:  2012-03

4.  Prevalence of the metabolic syndrome in patients with carotid disease according to NHLBI/AHA and IDF criteria: a cross-sectional study.

Authors:  Milos Z Maksimovic; Hristina D Vlajinac; Djordje J Radak; Jelena M Marinkovic; Jagoda B Jorga
Journal:  BMC Cardiovasc Disord       Date:  2012-01-31       Impact factor: 2.298

5.  The association of metabolic syndrome with left ventricular mass and geometry in community-based hypertensive patients among Han Chinese.

Authors:  Shuxia Wang; Kangxing Song; Xiyun Guo; Hao Xue; Nina Wang; Jingzhou Chen; Yubao Zou; Kai Sun; Hu Wang; Jinggui He; Rutai Hui
Journal:  J Res Med Sci       Date:  2015-10       Impact factor: 1.852

Review 6.  From Metabolic Syndrome to Neurological Diseases: Role of Autophagy.

Authors:  Jessica Maiuolo; Micaela Gliozzi; Vincenzo Musolino; Cristina Carresi; Federica Scarano; Saverio Nucera; Miriam Scicchitano; Francesca Bosco; Stefano Ruga; Maria Caterina Zito; Roberta Macri; Rosamaria Bulotta; Carolina Muscoli; Vincenzo Mollace
Journal:  Front Cell Dev Biol       Date:  2021-03-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.